DE VOS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DE VOS PHARMA
Largest movements
- Receivables within one year +€94,266
up €94,266 (+616.1%), from €15,301 to €109,567
of which Other amounts receivable: +€55,416
- Debts after one year -€93,033
down €93,033 (-16.5%), from €564,279 to €471,246
- Reserves +€92,384
up €92,384 (+12.0%), from €767,441 to €859,825
- Short-term financial debts +€50,000
up €50,000 (+50.0%), from €100,000 to €150,000
- Tax, wage and social debts +€24,860
up €24,860 (+203.7%), from €12,206 to €37,066
of which Taxes: +€24,860
- Gross operating margin +€50,762
up €50,762 (+37.7%), from €134,533 to €185,295
- Financial charges -€20,189
down €20,189 (-29.7%), from €67,928 to €47,739
- Taxes +€18,517
up €18,517 (+91.5%), from €20,247 to €38,763
- Financial income -€9,838
down €9,838 (-100.0%), from €9,838 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,910,205 | €1,995,699 | +€85,494 | +4.5% |
| Fixed assets | 21/28 | €1,871,161 | €1,861,032 | -€10,129 | -0.5% |
| Tangible fixed assets | 22/27 | €11,812 | €1,683 | -€10,129 | -85.7% |
| Furniture and vehicles | 24 | €11,812 | €1,683 | -€10,129 | -85.7% |
| Financial fixed assets | 28 | €1,859,349 | €1,859,349 | = | 0.0% |
| Current assets | 29/58 | €39,044 | €134,667 | +€95,623 | +244.9% |
| Amounts receivable within one year | 40/41 | €15,301 | €109,567 | +€94,266 | +616.1% |
| Trade receivables | 40 | €38 | €38,888 | +€38,850 | +101276.9% |
| Other amounts receivable | 41 | €15,262 | €70,679 | +€55,416 | +363.1% |
| Current investments | 50/53 | €9,033 | €9,033 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €12,347 | €15,157 | +€2,810 | +22.8% |
| Deferred charges and accrued income | 490/1 | €2,364 | €910 | -€1,454 | -61.5% |
| Total equity and liabilities | 10/49 | €1,910,205 | €1,995,699 | +€85,494 | +4.5% |
| Equity | 10/15 | €773,641 | €866,025 | +€92,384 | +11.9% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €767,441 | €859,825 | +€92,384 | +12.0% |
| Distributable reserves | 133 | €767,441 | €859,825 | +€92,384 | +12.0% |
| Amounts payable | 17/49 | €1,136,565 | €1,129,674 | -€6,891 | -0.6% |
| Amounts payable after more than one year | 17 | €564,279 | €471,246 | -€93,033 | -16.5% |
| Financial debts | 170/4 | €564,279 | €471,246 | -€93,033 | -16.5% |
| Amounts payable within one year | 42/48 | €572,285 | €654,842 | +€82,557 | +14.4% |
| Current portion of amounts payable after more than one year | 42 | €89,161 | €93,033 | +€3,872 | +4.3% |
| Financial debts | 43 | €100,000 | €150,000 | +€50,000 | +50.0% |
| Credit institutions | 430/8 | €100,000 | €150,000 | +€50,000 | +50.0% |
| Trade debts | 44 | €1,444 | €2,533 | +€1,089 | +75.4% |
| Suppliers | 440/4 | €1,444 | €2,533 | +€1,089 | +75.4% |
| Taxes, remuneration and social security | 45 | €12,206 | €37,066 | +€24,860 | +203.7% |
| Taxes | 450/3 | €10,206 | €35,066 | +€24,860 | +243.6% |
| Remuneration and social security | 454/9 | €2,000 | €2,000 | = | 0.0% |
| Other amounts payable | 47/48 | €369,474 | €372,210 | +€2,736 | +0.7% |
| Accrued charges and deferred income | 492/3 | €0 | €3,586 | +€3,586 | |
| Non-recurring operating income | 76A | - | €16,068 | +€16,068 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,881 | €4,138 | +€257 | +6.6% |
| Other operating charges | 640/8 | €2,202 | €2,271 | +€69 | +3.1% |
| Gross operating margin | 9900 | €134,533 | €185,295 | +€50,762 | +37.7% |
| Operating profit (loss) | 9901 | €128,450 | €178,886 | +€50,436 | +39.3% |
| Financial income | 75/76B | €9,838 | €0 | -€9,838 | -100.0% |
| Recurring financial income | 75 | €9,838 | €0 | -€9,838 | -100.0% |
| Financial charges | 65/66B | €67,928 | €47,739 | -€20,189 | -29.7% |
| Recurring financial charges | 65 | €67,928 | €47,739 | -€20,189 | -29.7% |
| Profit (loss) for the period before taxes | 9903 | €70,360 | €131,148 | +€60,788 | +86.4% |
| Income taxes | 67/77 | €20,247 | €38,763 | +€18,517 | +91.5% |
| Profit (loss) for the period | 9904 | €50,113 | €92,384 | +€42,271 | +84.4% |
| Profit (loss) for the period to be appropriated | 9905 | €50,113 | €92,384 | +€42,271 | +84.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.